Bhatt Nailesh's most recent trade in Hyperliquid Strategies Inc. was a trade of 2,455 Common Stock done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hyperliquid Strategies Inc | Nailesh Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 2,455 | 45,326 | - | 0 | Common Stock | |
| Hyperliquid Strategies Inc | Nailesh Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 40,789 | 42,871 | - | 0 | Common Stock | |
| Hyperliquid Strategies Inc | Nailesh Bhatt | Director | Other type of transaction at price $ 0.00 per share. | 02 Dec 2025 | 2,082 | 2,082 | - | - | Common Stock | |
| Sonnet BioTherapeutics Holdings Inc | Nailesh Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 10,000 | 10,547 | - | - | Common Stock | |
| Sonnet BioTherapeutics Holdings Inc | Bhatt Nailesh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 373 | 547 | - | - | Common Stock | |
| Sonnet BioTherapeutics Holdings Inc | Nailesh Bhatt | Director | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 17 May 2023 | 25,000 | 30,733 | - | 0.2 | 5,800 | Common Stock |
| Sonnet BioTherapeutics Holdings Inc | Nailesh Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 3,770 | 31,255 | - | - | Common Stock |